Oncol Res Treat. 2018;41(3):105-109. doi: 10.1159/000484608. Epub 2018 Feb 27.
The aim of this study was to compare the dosimetric parameters, clinical complications, and efficacy of volumetric modulated arc therapy (VMAT) and fixed-field intensity-modulated radiotherapy (f-IMRT) in radical radiotherapy for cervical cancer without lymphadenectasis.
84 cervical cancer patients undergoing treatment with VMAT and f-IMRT were selected. Dose-volume histograms were used to evaluate the dose distribution in the planning target volume (PTV) and organs at risk. The clinical complications and efficacy were observed.
The homogeneity index (HI) and the conformity index (CI) of VMAT plans were both superior to the HI and CI of f-IMRT plans (p = 0.043, 0.025). VMAT plans resulted in a reduction in the V30 of the rectum and V40 of the bladder (p = 0.002). Furthermore, the monitor units (MUs) for VMAT were less than a quarter of those for f-IMRT. The treatment time for VMAT was less than a half of that for f-IMRT. Both clinical complications and efficacy showed no significant differences.
VMAT plans showed superior dose coverage of the PTV, better protection of the rectum and bladder in dosimetry, and significantly reduced MUs and treatment time compared with f-IMRT. Clinical results were similar for both plans.
本研究旨在比较容积调强弧形治疗(VMAT)和固定野调强放疗(f-IMRT)在无淋巴结转移的宫颈癌根治性放疗中的剂量学参数、临床并发症和疗效。
选择 84 例接受 VMAT 和 f-IMRT 治疗的宫颈癌患者。采用剂量体积直方图评估计划靶区(PTV)和危及器官的剂量分布。观察临床并发症和疗效。
VMAT 计划的均匀性指数(HI)和适形性指数(CI)均优于 f-IMRT 计划的 HI 和 CI(p = 0.043,0.025)。VMAT 计划可降低直肠 V30 和膀胱 V40(p = 0.002)。此外,VMAT 的监测器单位(MU)比 f-IMRT 少四分之一。VMAT 的治疗时间也少于 f-IMRT 的一半。两种方案的临床并发症和疗效均无显著差异。
与 f-IMRT 相比,VMAT 计划在靶区剂量覆盖、直肠和膀胱的剂量保护方面具有优势,MU 和治疗时间明显减少。两种方案的临床结果相似。